No oncological concerns specific to the TREK-1 blockade mechanism have been identified
Phase 2 data published in the New England Journal of Medicine (2023) demonstrated substantial weight loss in adults with obesity, but the medicine is not yet approved for clinical use in the UK
Metallomics 5:13971410 Aslani MR, Najarnezhad V, Mohri M, Azad M (2011) The effect of allicin on blood and tissue lead content in mice
Each injection is a moment where dosing mistakes, contamination, and tissue damage can occur
IPCE Credit This activity was planned by and for the healthcare team, and learners will receive 1.25 Interprofessional Continuing Education (IPCE) credits for learning and change
[4] [5] Patients should be reassured that the medication is designed to work continuously, not just immediately after injection